United States: IRA Drug Price Negotiation Program Litigation Updates – Denial Of PI Motion And Motion To Dismiss In Chambers Of Commerce Case And New Complaint Filed By Novo Nordisk - Goodwin Procter LLP

Mondaq

03 Oct 2023 0 shares 1 views

United States: IRA Drug Price Negotiation Program Litigation Updates – Denial Of PI Motion And Motion To Dismiss In Chambers Of Commerce Case And New Complaint Filed By Novo Nordisk - Goodwin Procter LLP

Mondaq

Published 03 Oct 2023

On Friday, September 29, the court in Dayton Area Chamber of Commerce et al. v. Becerra et al. (S.D. Ohio, Judge Newman) issued the first substantive order addressing legal challenges...

Full Article

United States: Preliminary Injunction Decision In Chambers Of Commerce Case Provides First Insights Into Merits Of Medicare Negotiations Cases - Hyman, Phelps, & McNamara, P.C.

Last week, a federal court in Ohio denied a preliminary injunction motion by four Chambers of Commerce in their lawsuit against the..

Mondaq 27 Oct 2023

United States: IRA Drug Price Negotiation Program Litigation Updates – Denial Of PI Motion And Motion To Dismiss In Chambers Of Commerce Case And New Complaint Filed By Novo Nordisk - Goodwin Procter LLP

United States: IRA Drug Price Negotiation Program Litigation Updates – Denial Of PI Motion And Motion To Dismiss In Chambers Of Commerce Case And New Complaint Filed By Novo Nordisk - Goodwin Procter LLP

You might like

Related news coverage

United States: Preliminary Injunction Decision In Chambers Of Commerce Case Provides First Insights Into Merits Of Medicare Negotiations Cases - Hyman, Phelps, & McNamara, P.C.

Advertisement